1. Fokina AA, Stetsenko DA, François J-C. DNA enzymes as potential therapeutics: towards clinical application of 10-23 DNAzymes. Expert Opin Biol Ther. 2015; 15, 689-711. PMID: 25772532
2. Wang X, Zhang L, Ding N, Yang X, Zhang J, He J, et al. Identification and characterization of DNAzymes targeting DNA methyltransferase I for suppressing bladder cancer proliferation. Biochem Biophys Res Commun. 2015; 461(2):329-33. PMID: 25888794
3. Zhu J, Li Z, Yang Z, He J. Studies on the preferred uracil–adenine base pair at the cleavage site of 10-23 DNAzyme by functional group modifications on adenine. Bioorg Med Chem. 2015; 23(15):4256-63. PMID: 26145822
4. Fokina AA, Stetsenko DA, Francois JC. DNA enzymes as potential therapeutics: towards clinical application of 10-23 DNAzymes. Expert Opin Biol Ther. 2015; 15(5):689-711. PMID: 25772532
5. Krug N, Hohlfeld JM, Kirsten A-M, Kornmann O, Beeh KM, Kappeler D, et al. Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme. N Engl J Med. 2015; 372(21):1987-95. PMID: 25981191
6. Hou Z, Meng JR, Zhao JR, Hu BQ, Liu J, Yan XJ, et al. Inhibition of beta-lactamase-mediated oxacillin resistance in Staphylococcus aureus by a deoxyribozyme. Acta Pharmacol Sin. 2007; 28(11):1775-182. PMID: 17959028
7. Hou Z, Meng JR, Niu C, Wang HF, Liu J, Hu BQ, et al. Restoration of antibiotic susceptibility in methicillin‐resistant staphylococcus aureus by targeting mecr1 with a phosphorothioate deoxyribozyme. Clin Exp Pharmacol Physiol. 2007; 34(11):1160-4. PMID: 17880371
8. Chen F, Li Z, Wang R, Liu B, Zeng Z, Zhang H, et al. Inhibition of ampicillin-resistant bacteria by novel mono-DNAzymes and di-DNAzyme targeted to β-lactamase mRNA. Oligonucleotides. 2004; 14(2):80-9. PMID: 15294072
9. Hou W, Ni Q, Wo J, Li M, Liu K, Chen L, et al. Inhibition of hepatitis B virus X gene expression by 10-23 DNAzymes. Antiviral Res. 2006; 72(3):190-6. PMID: 16930733
10. Unwalla H, Banerjea AC. Novel mono-and di-DNA-enzymes targeted to cleave TAT or TAT-REV RNA inhibit HIV-1 gene expression. Antiviral Res. 2001; 51(2):127-39. PMID: 11431037
11. Li J, Zhu D, Yi Z, He Y, Chun Y, Liu Y, et al. DNAzymes targeting the icl gene inhibit ICL expression and decrease Mycobacterium tuberculosis survival in macrophages. Oligonucleotides. 2005; 15(3):215-22. PMID: 16201909
12. Horwitz JP, Chua J, Curby RJ, Tomson AJ, Da Rooge MA, Fisher BE, et al. Substrates for Cytochemical Demonstration of Enzyme Activity. I. Some Substituted 3-Indolyl-β-D-glycopyranosides1a. J Med Chem. 1964; 7(4):574-5.
13. Langley KE, Villarejo MR, Fowler AV, Zamenhof PJ, Zabin I. Molecular basis of beta-galactosidase alpha-complementation. Proc Natl Acad Sci U S A. 1975; 72(4):1254-7. PMID: 1093175
14. Markham NR, Zuker M. DINAMelt web server for nucleic acid melting prediction. Nucleic Acids Res. 2005; 33(Web Server issue):W577-81. PMID: 15980540
15. Sun L-Q, Cairns MJ, Gerlach WL, Witherington C, Wang L, King A. Suppression of smooth muscle cell proliferation by a c-myc RNA-cleaving deoxyribozyme. J Biol Chem. 1999; 274(24):17236-41. PMID: 10358082
16. Abe H. [Nanostructured RNA for RNA interference]. Yakugaku Zasshi. 2013; 133(3):373-8. PMID: 23449417
17. Nakashima Y, Abe H, Abe N, Aikawa K, Ito Y. Branched RNA nanostructures for RNA interference. Chem Commun (Camb). 2011; 47(29):8367-9. PMID: 21691656 [
DOI:10.1248/yakushi.12-00239-F]
18. Burnett JC, Rossi JJ. RNA-based therapeutics: current progress and future prospects. Chem Biol. 2012; 19(1):60-71. PMID: 22284355